×
About 2,343 results

ALLMedicine™ Apraxia Center

Research & Reviews  852 results

Micro- and Macrovascular Parameters in Delayed Cerebral Ischemia
https://clinicaltrials.gov/ct2/show/NCT05483751

Aug 4th, 2022 - BACKGROUND DCI following aSAH affects 30% of all aSAH-patients and is the leading cause of morbidity, mortality, prolonged hospitalization and neuropsychological disturbances in aSAH patients. DCI is defined as the occurrence of new focal deficits...

Automated Detection of Speech Timing Alterations in Autopsy-Confirmed Nonfluent/Agramma...
https://doi.org/10.1212/WNL.0000000000200750
Neurology García AM, Welch AE et. al.

Aug 2nd, 2022 - Motor speech function, including speech timing, is a key domain for diagnosing nonfluent/agrammatic variant primary progressive aphasia (nfvPPA). Yet, standard assessments use subjective, specialist-dependent evaluations, undermining reliability a...

Speech and language development and genotype-phenotype correlation in 49 individuals wi...
https://doi.org/10.1002/ajmg.a.62899
American Journal of Medical Genetics. Part A; St John M, Amor DJ et. al.

Jul 28th, 2022 - Pathogenic KAT6A variants cause syndromic neurodevelopmental disability. "Speech delay" is reported, yet none have examined specific speech and language features of KAT6A syndrome. Here we phenotype the communication profile of individuals with pa...

Perceptual Classification of Motor Speech Disorders: The Role of Severity, Speech Task,...
https://doi.org/10.1044/2022_JSLHR-21-00519
Journal of Speech, Language, and Hearing Research : JSLHR; Pernon M, Assal F et. al.

Jul 26th, 2022 - The clinical diagnosis of motor speech disorders (MSDs) is mainly based on perceptual approaches. However, studies on perceptual classification of MSDs often indicate low classification accuracy. The aim of this study was to determine in a forced-...

One century after Liepmann's work on apraxia: Where do we go now?
https://doi.org/10.1016/j.cortex.2022.06.007
Cortex; a Journal Devoted to the Study of the Nervous Sys... Bartolo A, Osiurak F

Jul 24th, 2022 - One century after Liepmann's work on apraxia: Where do we go now?|2022|Bartolo A,Osiurak F,|

see more →

Drugs  1 results see all →

Clinicaltrials.gov  64 results

Micro- and Macrovascular Parameters in Delayed Cerebral Ischemia
https://clinicaltrials.gov/ct2/show/NCT05483751

Aug 4th, 2022 - BACKGROUND DCI following aSAH affects 30% of all aSAH-patients and is the leading cause of morbidity, mortality, prolonged hospitalization and neuropsychological disturbances in aSAH patients. DCI is defined as the occurrence of new focal deficits...

Treatment Intensity - Apraxia of Speech
https://clinicaltrials.gov/ct2/show/NCT02332915

Jul 12th, 2022 - This research was designed to examine the effects of treatment intensity on outcomes associated with an established treatment for acquired apraxia of speech (AOS). Intensity in the form of dose frequency and total intervention duration was evaluat...

Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing
https://clinicaltrials.gov/ct2/show/NCT04394871

Jul 7th, 2022 - Objective: Amyotrophic lateral sclerosis type 4 (ALS4) is an inherited form of motor neuron disease caused by mutation in the senataxin (SETX) gene. The main goal of this study will be to collect clinical and molecular biomarkers from patients wit...

Apraxia in Parkinson's Disease Patients With Deep Brain Stimulation
https://clinicaltrials.gov/ct2/show/NCT04725773

Jun 30th, 2022 - This will be a pilot study designed to assess the safety and feasibility of an apraxia testing protocol in chronically implanted PD DBS patients. We hypothesize that apraxia testing in the DBS ON and OFF states will be a safe and well-tolerated te...

Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia
https://clinicaltrials.gov/ct2/show/NCT04486586

Jun 15th, 2022 - A. Evaluation Tasks Language Tasks: Participants will be administered baseline language and cognitive tasks, including 1 or more of the following, depending on participants' residual language and cognitive skills: a) writing to dictation b) oral s...

see more →

News  14 results

Inhaled Heroin Tied to 'Peculiar, Often Catastrophic' Brain Damage
https://www.medscape.com/viewarticle/899079

Jul 9th, 2018 - "Chasing the dragon" (CTD) — a method of inhaling heroin in which users heat heroin over aluminium foil with a lighter and then chase the fumes — is growing in popularity and may lead to "peculiar and often catastrophic brain complications," new r...

Can Botulinum Toxin Benefit People With Parkinson’s Disease?
https://www.mdedge.com/neurology/article/136563/parkinsons-disease/can-botulinum-toxin-benefit-people-parkinsons-disease

Apr 25th, 2017 - Robert Chen, MBBChir MIAMI—Botulinum toxin may be a clinically useful treatment for motor and nonmotor manifestations of Parkinson’s disease and parkinsonism, according to an overview presented at the First Pan American Parkinson’s Disease and Mov.

Alemtuzumab Linked to CNS Inflammation
https://www.medscape.com/viewarticle/875002

Jan 26th, 2017 - Two cases of what is suggested to be "the first recognised cases of severely exacerbated CNS [central nervous system] inflammation after alemtuzumab therapy in multiple sclerosis" have been published. Writing in a letter in the February issue of T...

Experts review challenges, pearls in young onset dementia
https://www.mdedge.com/psychiatry/article/113800/alzheimers-cognition/experts-review-challenges-pearls-young-onset-dementia
Amy Karon

Sep 19th, 2016 - SAN FRANCISCO – The patient, a man in his early 50s, smiled as he sang about flatulence. He seemed alert, relaxed, and aware of his wife and the neurologist in the room.

see more →

Patient Education  6 results see all →